We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Nuvo Receives Approvable Letter for Topical Osteoarthritis Treatment
Nuvo Receives Approvable Letter for Topical Osteoarthritis Treatment
December 29, 2006
The FDA issued an approvable letter for Nuvo’s topical non-steroidal anti-inflammatory drug Pennsaid to treat osteoarthritis of the knee, the company announced.